a Patient Navigation-based Preoperative Rehabilitation Exercise Program in Patients Undergoing TKA
Launched by ANNA SUN · Jul 1, 2025
Trial Information
Current as of July 22, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
On the day of admission, after being informed of the study and potential risks, all patients giving written informedconsent will immediately screening period to determine eligibility for study entry.patients who meet the eligibility requirements will be randomized in a single-blindmanner( (data collection personnel) in a 1:1 ratio to receive 3-7 day a patient navigation-based preoperative rehabilitation exercise program or a autonomous preoperative rehabilitation training program.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients diagnosed with knee osteoarthritis (KOA) scheduled to undergo primary unilateral total knee arthroplasty (TKA)
- • Assessed by the attending physician as medically fit to tolerate preoperative rehabilitation exercise, possessing effective communication skills, and capable of cooperating with all required examinations and assessments
- • Assessed as capable (either the patient or their caregiver) of using a smartphone to receive information
- Exclusion Criteria:
- • Individuals unable to cooperate due to impaired consciousness, cognitive impairment, or similar conditions
- • Concurrent severe comorbidities such as liver cirrhosis, respiratory failure, renal failure, malignant tumors, trauma, etc.
- • History of significant neuromuscular disorders or other joint diseases deemed by the attending physician to affect joint function
- • Hospital admission date \>7 days or \<3 days prior to the scheduled surgery date
- • Currently undergoing systematic lower limb functional exercise training within the past four weeks
About Anna Sun
Anna Sun is a dedicated clinical trial sponsor committed to advancing medical research through the support and oversight of innovative clinical studies. With a focus on ensuring ethical standards, participant safety, and scientific integrity, Anna Sun plays a pivotal role in facilitating the development of new therapies and improving patient outcomes.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Guangzhou, Guangdong, China
Patients applied
Trial Officials
Hong zhang
Principal Investigator
research team
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported